Clinical Trial Update: Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease [NA]

View source ↗

Summary

Clinical trial update evaluating the effect of perfluorohexyloctane (NovaTears) on tear film thickness in patients with mild to moderate dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• NovaTears (perfluorohexyloctane)

Snippet

Sponsor: Novaliq GmbH | Conditions: Dry Eye Disease | NA | Status: COMPLETED